Real-time enrollment status for this cerebral amyloid angiopathy clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 8:09 AM UTC
| NCT Number | NCT05709314 |
| Recruiting Status | Recruiting |
| Condition | Cerebral Amyloid Angiopathy |
| Phase | PHASE2 |
| Target Enrollment | 25 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Amydis Inc. |
| Last Updated on CT.gov | February 13, 2026 (Feb 13, 2026) |
As of July 19, 2026: Clinical trial NCT05709314 is currently recruiting participants. This phase2 study for cerebral amyloid angiopathy is actively seeking new participants at 1 location across the United States. The study is sponsored by Amydis Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05709314 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05709314 was last updated Feb 13, 2026 (February 13, 2026). HelloStudys verifies this status automatically.